Glaxosmithkline Pharmaceuticals Ltd
Healthcare | Mid Cap
Glaxosmithkline Pharmaceuticals Ltd. shows very strong financial health, primarily driven by exceptional profitability and robust growth. The company is extremely good at turning revenue into profit and provides excellent returns on the money invested in it. Its long-term stability is outstanding, as it operates with almost no debt, making it very resilient. The company is also expanding its earnings and market presence at an impressive rate. However, its efficiency in day-to-day operations presents a mixed picture. While it collects payments quickly, it is slower in selling its inventory and does not use its total capital base as effectively to generate sales. Its ability to cover short-term bills is adequate but shows some areas of pressure. The future outlook is positive, supported by strong growth and profitability, though attention to operational efficiency and investment in future assets are notable aspects of its financial story.
Latest Report
View AllThe Latest Reports Are Not Available at the Moment. We’ll Notify You Once They’re Available.
Latest News
View AllThe Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.
- Valuation MetricsNeutral
- Market Metrics
- Stock Reports
- Stock News
- Growth Ratio10.00
- Financial Ratio8.40
- Profitability Ratio10.00
- Efficiency Ratio7.00
- Coverage Ratio6.80
- Solvency Ratio10.00
- Liquidity Ratio6.20
- Peer Assessment
- Management AssessmentStrong
- Risk AssessmentBalanced
- 1 HourBullish
- 2 HoursBullish
- 4 HoursBullish
- 1 DayBullish
- 1 WeekBearish
- 1 MonthBearish
Glaxosmithkline Pharmaceuticals Ltd. shows very strong financial health, primarily driven by exceptional profitability and robust growth. The company is extremely good at turning revenue into profit and provides excellent returns on the money invested in it. Its long-term stability is outstanding, as it operates with almost no debt, making it very resilient. The company is also expanding its earnings and market presence at an impressive rate. However, its efficiency in day-to-day operations presents a mixed picture. While it collects payments quickly, it is slower in selling its inventory and does not use its total capital base as effectively to generate sales. Its ability to cover short-term bills is adequate but shows some areas of pressure. The future outlook is positive, supported by strong growth and profitability, though attention to operational efficiency and investment in future assets are notable aspects of its financial story.
Overall Valuation Score
P/E RATIO (TTM)
39.04
Industry Median
28.62
Mid Cap Median
36.34
P/E RATIO
38.14
P/B RATIO
17.40
Industry Median
3.17
Mid Cap Median
7.64
P/S RATIO
11.30
Industry Median
3.42
Mid Cap Median
6.30
Others
PEG RATIO
0.00
EV/EBITDA RATIO
28.36
The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹2332 as on Jun 21, 2026.
Unlock Live Chart
Please login to view interactive real-time technical charts powered by TradingView.
Markets Depth NSE
Buy Orders
Bid
Quantity
Orders
No buy depth
Total
0
0
Sell Orders
Ask
Quantity
Orders
No sell depth
Total
0
0
Markets Today NSE
High
0.00
Low
0.00
Open
0.00
Close
0.00
Prev Close
0.00
Avg Price
0.00
Volume
0
Last Traded Quantity
0
Last Traded Time
N/A
Price Movement Indicator
0.00
Today's Low
0.00
Today's High
The company is on an excellent growth trajectory. Despite some volatility in the past, its recent and projected performance shows strong and consistent expansion across key areas. Revenues, operating profits, and earnings per share are all growing robustly. This indicates strong market demand, effective management, and a positive outlook for the future. This comprehensive growth is a major strength and signals that the company is successfully increasing its size and value.
| Growth Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue Growth Rate | 12.03 | -0.79 | 6.21 | 8.54 | 1.95 |
| Operating Profit Growth Rate | 27.42 | 5.51 | 13.06 | 29.7 | 11.03 |
| Earnings Per Share (EPS) Growth | 373.23 | -63.96 | -3.38 | 57.19 | 11.69 |
| Asset Growth Rate | 48.73 | -28.19 | 6.91 | 15.49 | 5.26 |
| Net Income Growth Rate | 373.46 | -63.95 | -3.44 | 57.29 | 11.64 |
Revenue Growth Rate
Operating Profit Growth Rate
Earnings Per Share (EPS) Growth
Asset Growth Rate
Net Income Growth Rate
From a shareholder's viewpoint, the company's financial metrics are largely positive. It delivers strong earnings and cash flow per share, maintains a high book value, and provides generous dividends, all of which are attractive to investors. A potential point of caution is the relatively low level of investment in new capital assets. While current returns are strong, this low reinvestment could be a concern for sustaining long-term growth. Overall, the company is generating significant current value for its shareholders.
| Financial Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Adjusted Earnings Per Share (Adjusted EPS) | 99.64 | 34.91 | 38.88 | 51.72 | 60.41 |
| Cash Earnings Per Share (Cash EPS) | 104.32 | 40.06 | 39.05 | 58.88 | 65.21 |
| Book Value Per Share | 157.57 | 103.02 | 105.15 | 115.44 | 134.14 |
| Dividend Per Share (DPS) | 90.04 | 32.08 | 32.04 | 54.2 | 56.87 |
| Capital Expenditures (CapEx) | 1560 | 33 | 9 | 17 | 54 |
Adjusted Earnings Per Share (Adjusted EPS)
Cash Earnings Per Share (Cash EPS)
Book Value Per Share
Dividend Per Share (DPS)
Capital Expenditures (CapEx)
The company's profitability is outstanding across the board. It demonstrates a superior ability to convert sales into profit at every level, from gross margin to net margin. Furthermore, it generates exceptional returns on the money invested by both shareholders and lenders, as well as on its total assets. This high level of profitability is a cornerstone of the company's financial strength, indicating highly efficient operations, strong market positioning, and effective management.
| Profitability Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Gross Profit Margin | 21.17 | 22.69 | 24.29 | 29.66 | 32.52 |
| Return on Capital Employed (ROCE) | 37 | 36 | 51 | 63 | 65 |
| Return on Equity (ROE) | 63.65 | 35.09 | 33.2 | 47.57 | 45.7 |
| Return on Assets (ROA) | 16.45 | 24.17 | 25.56 | 28.7 | 30.27 |
| Operating Margin | 23.25 | 24.72 | 26.32 | 31.45 | 34.25 |
| Net Margin | 51.71 | 18.79 | 17.08 | 24.75 | 27.11 |
Gross Profit Margin
Return on Capital Employed (ROCE)
Return on Equity (ROE)
Return on Assets (ROA)
Operating Margin
Net Margin
The company's operational efficiency is a mixed bag. It excels in certain areas, showing a strong ability to generate sales from its physical assets and to collect payments from customers very quickly. These are significant strengths that benefit cash flow. On the other hand, it is less effective in other aspects. The company takes a relatively long time to sell its inventory, and it doesn't use its overall capital base very effectively to generate revenue. This indicates that while some parts of the operation are highly efficient, others are lagging.
| Efficiency Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Fixed Asset Turnover Ratio | 9.9 | 9.85 | 10.76 | 13.2 | 13.6 |
| Inventory Turnover Ratio | 4.78 | 5.05 | 5.31 | 5.24 | 5.49 |
| Receivables Turnover Ratio | 15.57 | 16.38 | 16.69 | 14.56 | 13.51 |
| Days Sales in Inventory Ratio | 76.36 | 72.28 | 68.74 | 69.66 | 66.48 |
| Receivable Days | 23.44 | 22.28 | 21.87 | 25.07 | 27.02 |
| Capital Turnover Ratio | 1.22 | 1.85 | 1.92 | 1.91 | 1.66 |
Fixed Asset Turnover Ratio
Inventory Turnover Ratio
Receivables Turnover Ratio
Days Sales in Inventory Ratio
Receivable Days
Capital Turnover Ratio
The company's capacity to cover its financial commitments is a tale of two extremes. On one hand, its ability to cover interest payments is outstandingly strong, primarily because it has very little debt. This signifies almost no risk from debt obligations. On the other hand, its earnings provide only a very thin cushion over its dividend payments. This suggests the dividend policy is aggressive relative to current profits, which could be a point of concern if earnings were to drop.
| Coverage Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Interest Coverage Ratio | 1047.5 | 420.5 | 409 | 1261 | 469.67 |
| Equity Dividend Coverage Ratio | 1.11 | 1.12 | 1.09 | 1.01 | 1.08 |
Interest Coverage Ratio
Equity Dividend Coverage Ratio
The company exhibits exceptional long-term financial stability. It has a very strong financial structure, characterized by an extremely low reliance on debt. The vast majority of its operations and assets are funded by its own capital (equity) rather than by borrowing. This is a major advantage, as it minimizes financial risk from interest rate changes and economic downturns. This position indicates a highly secure and independent company, which is very favorable for long-term sustainability.
| Solvency Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Debt Ratio | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Debt to Equity Ratio | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Equity Ratio | 0.99 | 0.99 | 0.99 | 0.99 | 0.99 |
| Debt To Asset Ratio | 0 | 0 | 0.01 | 0 | 0.01 |
Debt Ratio
Debt to Equity Ratio
Equity Ratio
Debt To Asset Ratio
The company's ability to meet its short-term financial obligations is mixed. On the positive side, it holds a healthy amount of cash and can cover immediate debts without needing to sell its inventory, which shows good financial cushioning. However, a downside is that its overall ability to cover all short-term liabilities has been tightening. Furthermore, the cash generated from its core business operations is relatively low compared to its immediate debts, indicating a reliance on other cash sources. Projections suggest some of these pressures may stabilize.
| Liquidity Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Current Ratio | 2 | 1.57 | 1.37 | 1.25 | 1.29 |
| Quick Ratio | 1.73 | 1.27 | 1.07 | 1.03 | 1.07 |
| Cash Ratio | 1.27 | 0.74 | 0.6 | 0.65 | 0.69 |
| Operating Cash Flow Ratio | 0.42 | 0.31 | 0.33 | 0.6 | 0.45 |
Current Ratios
Quick Ratios
Cash Ratios
Operating Cash Flow Ratios
Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.
| NO | Company Name | Health Score | P/E Ratio | Valuation | OPM | EPS | Latest Profit & Loss |
|---|---|---|---|---|---|---|---|
| 1 | Abbott India Ltd | 8.68 | 35.89 | Neutral | 1892.00 | 730.39 | 1552.00 |
| 2 | Glaxosmithkline Pharmaceuticals Ltd | 8.38 | 38.14 | Neutral | 1309.00 | 59.73 | 1036.00 |
| 3 | J B Chemicals & Pharmaceuticals Ltd | 8.14 | 49.64 | Overvalued | 1107.00 | 41.98 | 709.00 |
| 4 | Alkem Laboratories Ltd | 8.08 | 27.91 | Neutral | 3005.00 | 182.76 | 2351.00 |
| 5 | Gland Pharma Ltd | 7.91 | 35.27 | Overvalued | 1630.00 | 78.88 | 1027.00 |
| 6 | Neuland Laboratories Ltd | 7.84 | 61.14 | Highly Overvalued | 574.00 | 283.01 | 364.00 |
| 7 | Ajanta Pharma Ltd | 7.72 | 36.27 | Neutral | 1395.00 | 75.78 | 1056.00 |
| 8 | Alembic Pharmaceuticals Ltd | 7.54 | 22.23 | Undervalued | 1118.00 | 32.58 | 671.00 |
| 9 | Syngene International Ltd | 7.44 | 56.08 | Overvalued | 918.00 | 7.55 | 317.00 |
| 10 | Emcure Pharmaceuticals Ltd | 7.40 | 36.42 | Neutral | 1865.00 | 38.66 | 941.00 |
| 11 | ERIS Lifesciences Ltd | 7.15 | 32.39 | Neutral | 1120.00 | 17.61 | 648.00 |
| 12 | Laurus Labs Ltd | 7.10 | 85.84 | Neutral | 1778.00 | 13.72 | 890.00 |
| 13 | Glenmark Pharmaceuticals Ltd | 6.36 | 45.87 | Neutral | 4572.00 | -7.12 | 1362.00 |
| 14 | Ipca Laboratories Ltd | 6.33 | 35.26 | Neutral | 1979.00 | 44.64 | 1184.00 |
| 15 | Piramal Pharma Ltd | 5.83 | -64.86 | Neutral | 922.00 | 5.27 | -326.00 |
| 16 | Wockhardt Ltd | 5.07 | 153.40 | Neutral | 652.00 | 19.51 | 199.00 |
| 17 | Pfizer Ltd | 3.45 | 45.16 | Neutral | -82.00 | 157.92 | 300.00 |
Management effectiveness is rated Green, reflecting outstanding financial prudence and capital efficiency that outweigh concerns over growth. The company operates with virtually no debt, maintains an exceptional interest coverage ratio, and has consistently improved its return on capital employed (ROCE) to outstanding levels. This financial discipline is a significant strength. However, the assessment is tempered by weak and inconsistent top-line sales growth and highly volatile net profit, often influenced by large, non-recurring other income and exceptional items. While growth is a concern, the management's ability to generate superior returns and maintain a fortress balance sheet demonstrates strong core competency in managing the company's resources effectively.
| Category | Metric | Value | Assessment |
|---|---|---|---|
| PROS | Return on Capital Employed (ROCE) | 66.95% | excellent |
| Debt Management | Virtually Debt-Free | outstanding | |
| Capital Efficiency (CCC) | -4 Days (TTM) | very strong | |
| Promoter Holding | 75.00% | stable | |
| CONS | Compounded Sales Growth | 2% (TTM) | weak |
| Annual Profit Growth | Highly Volatile | inconsistent | |
| Reliance on Other Income | Significant & Volatile | poor |
Financial Performance & Growth
The company's financial performance presents a mixed picture characterized by weak top-line growth and volatile profitability. Compounded Sales Growth has been sluggish over multiple periods, with a 10-year CAGR of only 3% and a TTM growth of 2%. Annual sales figures have shown significant fluctuations, including periods of negative growth, indicating a lack of consistent revenue expansion.
While compounded profit growth appears strong in recent years (3-Year: 20%), the annual profit growth is extremely volatile, swinging from a 66% decline in FY20 to a 254% increase in FY22, followed by a 65% drop in FY23. This volatility is heavily influenced by large exceptional items and other income, as seen in FY22 where other income of ₹1,401 Cr was a primary driver of a ₹2,093 Cr PBT. This reliance on non-operational income obscures the true performance of the core business. Operating margins have shown a positive trend, but the inconsistency in sales and the volatile nature of net profit remain significant weaknesses in the company's financial performance.
| Metric | 2016-2018 Avg. | 2019-2021 Avg. | 2022-2024 Avg. |
|---|---|---|---|
| Avg. Sales Growth (%) | -4.3% | 0.9% | 5.8% |
| Avg. Profit Growth (%) | -11.0% | 63.3% | 66.7% |
Capital Efficiency & Returns
The management has demonstrated outstanding effectiveness in capital allocation and efficiency. The Return on Capital Employed (ROCE) has shown a strong and improving trend, rising from 22% in FY17 to 51% in FY24, with the current TTM ROCE standing at an impressive 66.95%. This indicates highly productive use of capital in generating profits. Similarly, the Return on Equity (ROE) has been consistently high, averaging 45% over the last three years and reaching 48.9% in the last year, delivering strong returns to shareholders.
Working capital management is another area of exceptional strength. The Cash Conversion Cycle (CCC) has improved dramatically, moving from 50 days in FY21 to a negative value of -4 days in the trailing twelve months (TTM). A negative CCC signifies that the company is effectively using its suppliers' credit to finance its operations and collect cash from customers before it has to pay its suppliers. This superior efficiency in managing receivables, inventory, and payables frees up cash and underscores operational prowess.
| Metric | 2017-2019 Avg. | 2020-2022 Avg. | 2023-2024 Avg. |
|---|---|---|---|
| ROCE (%) | 26.3% | 36.0% | 43.5% |
| Cash Conversion Cycle (Days) | 37.7 | 35.7 | 13.5 |
Financial Health & Prudence
The company's financial health is exceptionally strong, reflecting a highly prudent management approach. It is virtually debt-free, with borrowings at a negligible ₹19 Cr as of March 2024 against total equity of ₹1,777 Cr. This results in a debt-to-equity ratio that is effectively zero, insulating the company from financial leverage risks and interest rate fluctuations. Consequently, the Interest Coverage Ratio is extremely robust; with an operating profit of ₹909 Cr and interest expense of just ₹2 Cr in FY24, the ratio stands at an astronomical 454.5, indicating an overwhelming capacity to cover its minimal interest obligations. Furthermore, the company has a consistent history of sharing profits with shareholders, as evidenced by a high dividend payout ratio, which was 92% in FY24. This combination of a pristine balance sheet, minimal debt, and consistent shareholder returns highlights a commitment to financial stability.
Shareholding & Ownership Structure
The ownership structure reflects strong promoter confidence and growing interest from foreign institutional investors. The promoter holding is stable at 75.00%, the maximum permissible level for a non-government entity in India. This high and unwavering stake signals a long-term commitment and alignment of the promoters' interests with those of other shareholders. While Domestic Institutional Investor (DII) holding has seen a decline from 10.25% in June 2023 to 7.90% in March 2024, this has been partly offset by a positive trend in Foreign Institutional Investor (FII) holding. FIIs have steadily increased their stake from 2.41% to 3.48% over the same period. This increasing FII participation indicates growing confidence from global investors in the company's prospects and governance. The overall structure is stable, providing a solid foundation for the company.
The overall risk is assessed as moderate. While the company boasts a fortress balance sheet with virtually no debt, providing a very low financial risk profile, there are tangible risks associated with its operational performance and earnings quality. The primary concerns are the persistent lack of consistent sales growth and the high volatility in reported net profits. Earnings are frequently influenced by large, unpredictable 'Other Income' and 'Exceptional Items,' which complicates the assessment of core business profitability and future earnings potential. This volatility in earnings, combined with anemic top-line growth, presents a risk to long-term value creation, even though the company's immediate financial stability is not in question.
Earnings Quality
The quality of reported earnings presents a notable risk due to significant volatility and reliance on non-operational items. The profit and loss statements frequently feature large 'Exceptional Items' and 'Other Income' that distort the underlying performance of the core business. For instance, fiscal year 2022 saw net profit surge due to other income of ₹1,401 Cr, which was not related to primary operations. Conversely, fiscal year 2020 was impacted by a negative other income of -₹262 Cr and a negative exceptional item of -₹339 Cr. This pattern of large, irregular items makes earnings less predictable and of lower quality. Furthermore, the dividend payout of 727% in FY20 is a significant red flag, indicating a payment far in excess of earnings for that year, which points to unusual financial activities that are not sustainable.
0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 1 Hour Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bearish
- IndicatorValueSignal
- SMA 102296.79Bullish
- SMA 202247.23Bullish
- SMA 502181.78Bullish
- EMA 102296.98Bullish
- EMA 202261.05Bullish
- EMA 502215.12Bullish
- DEMA 102336.34Bullish
- DEMA 202315.54Bullish
- DEMA 502246.33Bullish
- TEMA 102342.72Bullish
- TEMA 202338.97Bullish
- TEMA 502293.45Bullish
- MACD42.56Bullish
- ADX49.60Strong Trend
- IndicatorValueSignal
- RSI79.94Overbought
- CCI130.61Overbought
- ROC 94.51Bullish
- ROC 146.98Bullish
- ROC 258.82Bullish
- Stoch K92.73Overbought
- Stoch D88.50Overbought
- IndicatorValueSignal
- BB Upper2359.45Neutral
- BB Middle2247.23Neutral
- BB Lower2135.01Neutral
- ATR23.33High Volatility
- IndicatorValueSignal
- MFI98.01Overbought
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 2 Hours Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bearish
- IndicatorValueSignal
- SMA 102262.74Bullish
- SMA 202212.70Bullish
- SMA 502181.77Bullish
- EMA 102274.28Bullish
- EMA 202234.11Bullish
- EMA 502211.69Bullish
- DEMA 102326.61Bullish
- DEMA 202283.80Bullish
- DEMA 502197.95Bullish
- TEMA 102344.95Bullish
- TEMA 202322.77Bullish
- TEMA 502238.25Bullish
- MACD41.69Bullish
- ADX36.87Strong Trend
- IndicatorValueSignal
- RSI77.82Overbought
- CCI166.48Overbought
- ROC 96.67Bullish
- ROC 147.90Bullish
- ROC 2511.34Bullish
- Stoch K93.69Overbought
- Stoch D91.07Overbought
- IndicatorValueSignal
- BB Upper2343.37Overbought
- BB Middle2212.70Neutral
- BB Lower2082.03Neutral
- ATR30.09Low Volatility
- IndicatorValueSignal
- MFI89.82Overbought
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 4 Hours Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 102214.03Bullish
- SMA 202183.42Bullish
- SMA 502242.44Bullish
- EMA 102235.93Bullish
- EMA 202211.29Bullish
- EMA 502240.78Bullish
- DEMA 102285.21Bullish
- DEMA 202220.04Bullish
- DEMA 502176.55Bullish
- TEMA 102321.30Bullish
- TEMA 202266.52Bullish
- TEMA 50N/AN/A
- MACD14.39Bullish
- ADX26.93Strong Trend
- IndicatorValueSignal
- RSI70.35Overbought
- CCI236.13Overbought
- ROC 99.16Bullish
- ROC 148.01Bullish
- ROC 258.15Bullish
- Stoch K92.83Overbought
- Stoch D92.21Overbought
- IndicatorValueSignal
- BB Upper2308.30Overbought
- BB Middle2183.42Neutral
- BB Lower2058.55Neutral
- ATR42.30High Volatility
- IndicatorValueSignal
- MFI75.47Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Market Sentiment
Analysis Driven By 33 Technical Indicators From The 1 Day Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 102190.14Bullish
- SMA 202210.11Bullish
- SMA 502330.78Bullish
- SMA 1002397.71Bearish
- SMA 2002502.41Bearish
- EMA 102219.12Bullish
- EMA 202232.49Bullish
- EMA 502301.54Bullish
- EMA 1002377.29Bearish
- EMA 2002475.57Bearish
- DEMA 102231.84Bullish
- DEMA 202184.30Bullish
- DEMA 502211.00Bullish
- DEMA 1002246.48Bullish
- DEMA 2002352.06Bearish
- TEMA 102275.07Bullish
- TEMA 202196.17Bullish
- TEMA 502182.06Bullish
- TEMA 1002217.84Bullish
- TEMA 2002211.68Bullish
- MACD-30.06Bullish
- ADX30.39Strong Trend
- IndicatorValueSignal
- RSI60.15Neutral
- CCI123.15Overbought
- ROC 145.79Bullish
- ROC 25-3.50Bearish
- Stoch K83.43Overbought
- Stoch D65.08Neutral
- IndicatorValueSignal
- BB Upper2338.74Neutral
- BB Middle2210.10Neutral
- BB Lower2081.47Neutral
- ATR60.82High Volatility
- IndicatorValueSignal
- MFI59.38Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Market Sentiment
Analysis Driven By 21 Technical Indicators From The 1 Week Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bearish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 202396.37Bearish
- SMA 502581.16Bearish
- EMA 202370.47Bearish
- EMA 502494.03Bearish
- DEMA 202247.89Bearish
- DEMA 502407.45Bearish
- TEMA 202221.77Bearish
- TEMA 502240.95Bearish
- MACD-94.26Bearish
- ADX26.56Strong Trend
- IndicatorValueSignal
- RSI38.26Neutral
- CCI-148.10Oversold
- ROC 14-15.72Bearish
- ROC 25-16.11Bearish
- Stoch K4.29Oversold
- Stoch D11.72Oversold
- IndicatorValueSignal
- BB Upper2661.89Neutral
- BB Middle2396.37Neutral
- BB Lower2130.85Oversold
- ATR141.48Low Volatility
- IndicatorValueSignal
- MFI35.36Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Market Sentiment
Analysis Driven By 25 Technical Indicators From The 1 Month Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bearish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 62379.40Bearish
- SMA 122621.66Bearish
- SMA 242639.24Bearish
- EMA 62382.48Bearish
- EMA 122490.77Bearish
- EMA 242464.83Bearish
- DEMA 62243.44Bearish
- DEMA 122397.45Bearish
- DEMA 242652.21Bearish
- TEMA 62209.54Bullish
- TEMA 122229.40Bearish
- TEMA 242532.89Bearish
- MACD265.17Bearish
- ADX21.87Weak Trend
- IndicatorValueSignal
- RSI50.75Neutral
- CCI26.55Neutral
- ROC 255.92Bullish
- ROC 5032.59Bullish
- Stoch K52.64Neutral
- Stoch D68.76Neutral
- IndicatorValueSignal
- BB Upper3345.03Neutral
- BB Middle2623.22Neutral
- BB Lower1901.41Neutral
- ATR361.13Low Volatility
- IndicatorValueSignal
- MFI53.60Neutral